Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGs Chain Regulatory News (GSC)

  • This share is currently suspended. It was suspended at a price of 0.25

Share Price Information for Gs Chain (GSC)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.12m
GSC Live PriceLast checked at - London Stock Exchange

Intraday Gs Chain Share Chart

Convertible Investment Agreement

4 Mar 2026 07:30

RNS Number : 1859V
GS Chain PLC
04 March 2026

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED WHICH, BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, FORMS PART OF UK LAW. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE ("RIS"), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

GS CHAIN PLC("GS Chain" or the "Company")

Convertible Investment Agreement

The Company announces that it has entered into a termination and settlement agreement ("Termination Agreement") with Citymeade Limited (the "Investor") to terminate the Convertible Investment Agreement entered into between the parties on 15 October 2025 ("Investment Agreement").

The Investor has, as at the date of this announcement, advanced approximately £120,000 to the Company pursuant to the terms of the Investment Agreement. In accordance with, and in full and final settlement of, its obligations under the Investment Agreement, the Company has agreed to issue 48,000,000 new ordinary shares of £0.000167 each in the share capital of the Company ("Shares") to the Investor and immediately following the issue of the Shares, the Investment Agreement shall automatically terminate in accordance with the terms of the Termination Agreement.

The issue of the Shares to the Investor is subject to customary conditions, including but not limited to the directors of the Company having the sufficient authority to issue the Shares. The Company intends to issue the Shares to the Investor as soon as possible following obtaining such authorities, which it expects to do at its annual general meeting which is to be held later today.

A further announcement will be made in due course to confirm the allotment and proposed date of admission of the Shares to to trading on the main market for listed securities of the London Stock Exchange.

- Ends -

For further information please contact:

Paul Carroll, Director

Paul@gschain.com

Bowsprit Partners Limited, Financial Adviser

John Treacy / Luis Brime

+44 (0)203 883 4430

Cairn Financial Advisers LLP, Sponsor

Emily Staples

+44 (0)20 7213 0897

Caution regarding forward looking statement:

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identi?ed by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward-looking statements re?ect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 ("UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AGRFLFVRVSIVIIR
Date   Source Headline
22nd May 202610:59 amRNSDirector Resignation
8th May 20262:33 pmRNSInterim Results - 31 December 2025
24th Apr 20267:00 amRNSDirector Resignation and Appointment of Chairman
14th Apr 20268:00 amRNSAllotment and Admission of New Shares
4th Mar 20262:26 pmRNSResult of AGM
4th Mar 20267:30 amRNSConvertible Investment Agreement
17th Feb 20267:39 amRNSProposed Acquisition and Suspension of Trading
9th Feb 20267:00 amRNSDirector Appointment
6th Feb 20267:00 amRNSFurther re: Notice of AGM
3rd Feb 202611:00 amRNSNotice of AGM
8th Dec 20254:45 pmRNSCorporate Update
17th Nov 20252:49 pmRNSDirector/PDMR Shareholding
31st Oct 20256:05 pmRNSAudited Results
16th Oct 20259:16 amRNSConvertible Investment Agreement
3rd Sep 20253:57 pmRNSUpdate to Listing Rules for Shell Companies
31st Mar 20257:00 amRNSInterim Results - 31 December 2024
4th Mar 20257:00 amRNSBoard Change
24th Jan 20257:00 amRNSBoard Change and Change of Adviser
17th Dec 20244:21 pmRNSResults of Annual General Meeting
31st Oct 202412:02 pmRNSAudited Results And Notice of AGM
2nd Sep 202410:44 amRNSDelisting from the US OTCQB Market
28th Mar 20247:00 amRNSHalf-Year Results
7th Dec 202311:34 amRNSResults of Annual General Meeting
8th Nov 20235:00 pmRNSNotice of Annual General Meeting
31st Oct 20233:02 pmRNSAudited Results
11th Apr 20231:48 pmRNSCommencement of Trading on US OTCQB Venture Market
31st Mar 20237:00 amRNSHalf-Year Results
16th Dec 20224:28 pmRNSResults of Annual General Meeting 2022
23rd Nov 202212:26 pmRNSNotice of Annual General Meeting
9th Nov 20221:30 pmRNSIntention to Cross-Trade on OTC Markets Group
31st Oct 20221:02 pmRNSAudited Results
3rd Oct 20229:31 amRNSChange in Accounting Reference Date
13th May 20228:00 amRNSAdmission to trading and first day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.